Concepedia

Author

Mélanie Rouillier

University of OxfordORCID

Also Known As

M Rouillier, Melanie Rouillier, Mélanie Rouillier

11

Publications

567

Citations

8

H-Index

5

Concepts

All Affiliations

University of OxfordMahidol UniversityAddex Therapeutics (Switzerland)Mahidol Oxford Tropical Medicine Research UnitMedicines for Malaria Venture
MR

About

Mélanie Rouillier is an author at University of Oxford specializing in pharmacotherapy, neuropharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

28

2

Pharmacology

1

1

28

3

Drug Discovery

1

1

28

4

Neuropharmacology

1

1

28

5

Pharmacotherapy

1

1

28

Mélanie Rouillier

×

7

Publications

550

Citations

7

H-Index

YearCitations

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

Alison Roth, Steven P. Maher, Amy J. Conway,

Nature Communications

2018

190

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials

Yevgeniya Antonova‐Koch, Stephan Meister, Matthew Abraham,

Science

2018

136

ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization

Mikhail Kalinichev, Mélanie Rouillier, Françoise Girard,

Journal of Pharmacology and Experimental Therapeutics

2012

97

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistance

James M. Murithi, Cécile Pascal, Jade Bath,

Science Translational Medicine

2021

49

Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro

Steven P. Maher, Amélie Vantaux, Victor Chaumeau,

Scientific Reports

2021

31

The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity

Mikhail Kalinichev, Françoise Girard, Hasnaà Haddouk,

Neuropharmacology

2016

28

Evaluation of peripheral versus central effects of <scp>GABA<sub>B</sub></scp> receptor activation using a novel, positive allosteric modulator of the <scp>GABA<sub>B</sub></scp> receptor <scp>ADX</scp>71943, a pharmacological tool compound with a fully peripheral activity profile

Mikhail Kalinichev, Tansy Donovan-Rodríguez, F Girard,

British Journal of Pharmacology

2014

19

Page 1